Nakahara Tsutomu, Maruko Takeshi, Sakamoto Kenji, Ishii Kunio
Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan
Biol Pharm Bull. 2004 Feb;27(2):239-41. doi: 10.1248/bpb.27.239.
We examined the basal adenosine 3',5'-cyclic monophosphate (cAMP) levels and forskolin-induced cAMP accumulation in cultured Chinese hamster ovary cells (CHO) expressing different levels of human beta(2)-adrenoceptors. Both the basal and forskolin-induced cAMP accumulation in the cells that express higher density of beta(2)-adrenoceptors (CHO-beta(2)/H; 560 fmol/mg protein) were larger than those in the cells that express lower density of beta(2)-adrenoceptors (CHO-beta(2)/L; 270 fmol/mg protein). In addition, isoproterenol-induced cAMP accumulation was also augmented as the number of beta(2)-adrenoceptors was increased. ICI 118,551, a selective beta(2)-adrenoceptor antagonist with inverse agonist properties, decreased all the levels of cAMP observed in both cell lines. These results suggest that the agonist-independent (constitutive) activity of beta(2)-adrenoceptors plays a key role in the control of forskolin-induced cAMP accumulation.
我们检测了表达不同水平人β₂ - 肾上腺素能受体的培养中国仓鼠卵巢细胞(CHO)中的基础3',5'-环磷酸腺苷(cAMP)水平以及福斯可林诱导的cAMP积累。表达较高密度β₂ - 肾上腺素能受体的细胞(CHO-β₂/H;560 fmol/mg蛋白质)中的基础cAMP水平和福斯可林诱导的cAMP积累均高于表达较低密度β₂ - 肾上腺素能受体的细胞(CHO-β₂/L;270 fmol/mg蛋白质)。此外,随着β₂ - 肾上腺素能受体数量的增加,异丙肾上腺素诱导的cAMP积累也增强。ICI 118,551是一种具有反向激动剂特性的选择性β₂ - 肾上腺素能受体拮抗剂,它降低了两种细胞系中观察到的所有cAMP水平。这些结果表明,β₂ - 肾上腺素能受体的非激动剂依赖性(组成性)活性在福斯可林诱导的cAMP积累控制中起关键作用。